ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /化合物

1,4-ジヒドロ-2,6-ジメチル-4-(3-ニトロフェニル)-3,5-ピリジンジカルボン酸3-[2-[4-(ジフェニルメチル)ピペラジン-1-イル]エチル]5-メチル

Manidipine

HCID 4008
反応を作成
印刷
基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
89226-50-6
標準SMILES
COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN2CCN(C(c3ccccc3)c3ccccc3)CC2)C1c1cccc([N+](=O)[O-])c1
InChIKey
ANEBWFXPVPTEET-UHFFFAOYSA-N
分子式
C35H38N4O6
平均分子量
610.7 g/mol
単同位体質量
610.27913494

概要

Manidipine is a diarylmethane.

名称と識別子

優先名称
Manidipine
IUPAC
5-O-[2-(4-benzhydrylpiperazin-1-yl)ethyl] 3-O-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
現地名
1,4-ジヒドロ-2,6-ジメチル-4-(3-ニトロフェニル)-3,5-ピリジンジカルボン酸3-[2-[4-(ジフェニルメチル)ピペラジン-1-イル]エチル]5-メチル
英語名
Manidipine
分子式
C35H38N4O6
分子量
610.7

名称と別名

manidipine89226-50-6FranidipineArtedilManidipine 63005-O-[2-(4-benzhydrylpiperazin-1-yl)ethyl] 3-O-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylateManidipino6O4754US88DTXSID20437452-(4-Diphenylmethyl-1-piperazinyl)ethyl methyl-1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate3-{2-[4-(diphenylmethyl)piperazin-1-yl]ethyl} 5-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylatemanidipinum
名称をさらに表示
1,4-ジヒドロ-2,6-ジメチル-4-(3-ニトロフェニル)-3,5-ピリジンジカルボン酸5-メチル3-[2-[4-(ジフェニルメチル)-1-ピペラジニル]エチル]マニジピン1,4-ジヒドロ-2,6-ジメチル-4-(3-ニトロフェニル)ピリジン-3,5-ジカルボン酸3-[2-[4-(ジフェニルメチル)ピペラジン-1-イル]エチル]5-メチル1,4-ジヒドロ-2,6-ジメチル-4-(3-ニトロフェニル)-3,5-ピリジンジカルボン酸3-[2-[4-(ジフェニルメチル)ピペラジン-1-イル]エチル]5-メチル2,6-ジメチル-4-(3-ニトロフェニル)-1,4-ジヒドロピリジン-3,5-ジカルボン酸3-[2-[4-(ジフェニルメチル)-1-ピペラジニル]エチル]5-メチル1,4-ジヒドロ-2,6-ジメチル-4-(3-ニトロフェニル)-3,5-ピリジンジカルボン酸3-メチル5-[2-[4-(ジフェニルメチル)-1-ピペラジニル]エチル]3-{2-[4-(ジフェニルメチル)ピペラジン-1-イル]エチル} 5-メチル 2,6-ジメチル-4-(3-ニトロフェニル)-1,4-ジヒドロピリジン-3,5-ジカルボキシラート2,6-ジメチル-4-(3-ニトロフェニル)-1,4-ジヒドロピリジン-3,5-ジカルボン酸3-[2-[4-(ジフェニルメチル)ピペラジノ]エチル]5-メチル2,6-ジメチル-4-(3-ニトロフェニル)-1,4-ジヒドロピリジン-3,5-ジカルボン酸=3-{2-[4-(ジフェニルメチル)-1-ピペラジニル]エチル}=5-メチルManidipine (Manyper)IpertenManidipine(base)Manidipine(CV-4093)Manidipine Impurity1254Manidipine (10mM in DMSO)
3-(2-(4-(diphenylmethyl)piperazin-1-yl)ethyl) 5-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate5-O-(2-(4-benzhydrylpiperazin-1-yl)ethyl) 3-O-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylatemanidipine, (+-)-RefChem:809939DTXCID0023745C08CA11120092-68-43-(2-(4-Benzhydrylpiperazin-1-yl)ethyl) 5-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate

データベース識別子

CAS
89226-50-6
PubChem CID
4008
DTXSID
DTXSID2043745
ChEMBL
CHEMBL1085699、CHEMBL312176
ChEBI
CHEBI:135849
UNII
6O4754US88
EC Number
855-394-4
Nikkaji
J313.870D

物性

構造計算による物性

XLogP
5.6
極性表面積
117 Ų
水素結合供与体数
1
水素結合受容体数
9
回転可能結合数
11
重原子数
45
形式電荷
0
複雑度
1,090

実験および物理化学的性質

DrugsPharmaceuticals
LogP5.2
Solubility<1mg/mL

物理化学的性質

融点
125 · 125-128°C
沸点
722 · 722.0±60.0 °C(Predicted)
比重(密度)
1.232 · 1.232±0.06 g/cm3(Predicted)
貯蔵温度
2 · Sealed in dry,2-8°C
溶解性
10 mM · Soluble in DMSO > 10 mM
外見
Powder
酸解離定数(Pka)
6.12 · 6.12±0.10(Predicted)
色
Light yellow to yellow
LogP
4.135 · 4.135

化学的性質

化学的特性Light Yellow Crystalline Solid

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

GHS分類

GHS Classification · 4 件

Danger

H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]

P264, P270, P301+P316, P321, P330, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 3 reports by companies from 1 notifications to the ECHA C&L Inventory.

危険有害性情報

Regulatory InformationREACH registered substance: 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 2-(4-(diphenylmethyl)-1-piperazinyl)ethyl methyl ester (EC: 855-394-4)
Hazard Classes and CategoriesAcute Tox. 3 (100%)

毒性情報

Drug Induced Liver Injury · 4 件

Drug-Induced Liver Injury Severity and Toxicity (DILIst)

Manidipine

DILI Positive

DOI:10.1016/j.drudis.2019.09.022

安全データ

注意喚起語
警告
危険有害性情報
コード 危険有害性情報 危険有害性クラス 区分 注意喚起語 シンボル P コード H302

化学と産業

薬理情報

ATC Code · 2 件

C - Cardiovascular system

QC - Cardiovascular system

Protein BindingManidipine is 99% bound to human plasma proteins.
PharmacodynamicsManidipine produces vasodilation resulting in lower blood pressure.
Mechanism of Action · 1 件

Contraction of vascular smooth muscle is stimulated by Gq coupled receptors which produce calcium release from the sarcoplasmic reticulum. This is followed by opening of voltage dependent calcium channels and an influx of calcium into the cell ultimately producing contraction. Manidipine binds to and dissociates slowly from L- and T-type voltage dependent calcium channels on smooth muscle cells, blocking the entrance of extracellular calcium into the cell and preventing this contraction. This produces vasodilation which decreases blood pressure. Manidipine produces renal vasodilation and an increase in natriuresis. This likely contributes to the antihypertensive effect by reducing blood volume. Manidipine is selective for the vasculature and does not produce significant effects on the heart or central nervous system at clinically relevant dosages.

Biological Half-LifeThe half life of elimination has been observed to be dose dependent. Doses of 5, 10, and 20 mg produced half lives of 3.94, 5.02, and 7.95 h respectively.
Metabolism/MetabolitesManidipine is extensively metabolized by CYP enzymes to pyridine derivatives and diphenylmethane derivatives which make up 4-7% and 22-24% of the dose excreted in the urine.
MeSH Pharmacological Classification · 2 件

Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS.

A class of drugs that act by selective inhibition of calcium influx through cellular membranes.

Absorption, Distribution and Excretion · 2 件

The median Tmax is 1.5 h. Administration with food produces an 1.3-1.6-fold increase in Cmax but no change in Tmax. Manidipine does not accumulate significantly with multiple doses.

Manidipine is eliminated through extensive metabolism. 63% is eliminated in the feces and 31% in the urine as metabolites.

用途と製造

UsesUse (kg; approx.) in Germany (2009): >25
応用分野 · 2 件

説明Manidipine is a dihydropyridine L- and T-type calcium channel blocker. It blocks recombinant rabbit L-type (α1Cα2/δβ1a) and human T-type (α1H) calcium channels expressed in Xenopus oocytes and native L-type channels in dissociated guinea pig cardiac ventricular cells (IC50 = 2.6 nM). Manidipine inhibits intracellular calcium increases induced by endothelin-1 (ET-1; ) in A7r5 rat vascular smooth muscle cells (ED50 = 1 nM) and potassium-induced contraction of isolated dog femoral and portal veins (IC50s = 24 and 2.1 nM, respectively). In vivo, it lowers blood pressure in spontaneously hypertensive rats (SHRs) when administered at a dose of 10 mg/kg and inhibits left ventricular hypertrophy in rats induced by isoproterenol when administered at a dose of 3 mg/kg. Formulations containing manidipine have been used in the treatment of hypertension.

使用Manidipine (Manyper) is a lipophilic, third-generation, highly vasoselective dihydropyridine calcium antagonist with an IC50 of 2.6 nM. It causes systemic vasodilation by inhibiting the voltage-dependent calcium inward currents in smooth muscle cells. It

上流・下流製品情報

上流原料

マニジピンジケテン3-アミノクロトン酸メチルマニジピン二塩酸塩1-ピペラジンエタノールイソプロピルエーテル硫酸マグネシウム (無水)2-(4-Benzhydrylpiperazino)ethyl acetoacetate1,4-ジヒドロ-2,6-ジメチル-4-(3-ニトロフェニル)ピリジン-3,5-ジカルボン酸5-メチル2-(4-benzhydrylpiperazin-1-yl)ethanol2-(3-ニトロベンジリデン)アセト酢酸メチル3-ニトロベンズアルデヒド1-ベンズヒドリルピペラジン

関連反応

2 件
反応記録を作成
HRID 1475169 の反応式
HRID 1475169生成物として
HRID 1475170 の反応式
HRID 1475170反応物として

化合物ノート

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート